Timolol Articles
Beximco Pharma enters EU generics market
12 February 2013
Allergan's 4th-qtr profit falls 6% on 3% sales drop
16 February 2009
Hi-Tech reports record sales for 2nd-qtr 2008
22 December 2008
Court denies Hi-Tech Pharmacal
22 December 2008
List of new CHMP drug recommendations
6 October 2008
Stock Commentary - New York week to June 2, 2008
9 June 2008
Allergan's Ganfort beats Xalacom in trial
9 June 2008
Allergan gains FDA appro for Combigan
12 November 2007
Small number of combination drugs reaching the Japanese market
24 September 2007
Combigen gets FDA approvable letter
8 January 2007
ISTA in-licenses two opthalmology drugs from Senju
26 June 2006
Headlines 25 years ago this week....
19 June 2006
EC approval for Allergan
5 June 2006
Headlines 25 years ago this week....
3 April 2006
Australian PBS new Rx listings aimed at seniors
11 April 2005
ISTA debuts Vitrase in USA
10 January 2005
ISTA sees 3rd-qtr net loss widen
1 November 2004
ISTA launches glaucoma drug Istalol in the USA
9 August 2004
ISTA's net loss widens in 2nd-qtr 2004
19 July 2004
US sales growth boosts Santen results
31 May 2004
Tokyo pharma stocks - week to May 17
24 May 2004
Tokyo pharma stocks - week to Jan 5
5 January 2004
Santen and J&J sign accord
5 January 2004
France to reimburse drugs at generics prices
30 June 2003
Xalacom outperforms Cosopt in glaucoma
13 May 2002
Celebrex approved for pain indication in USA
24 October 2001
Pharmacia launches Xalacom in UK
22 October 2001
Pharmacia earnings up 20%, sales rise 5%
25 July 2001
Pharmacia gets Xalcom approvable letter
26 October 2000
Allergan's Lumigan "better than timolol"
26 October 2000
Spanish drugmakers adapt to advent of generics regime
15 September 2000
Pharmacia's Xalcom approvable in USA
15 June 2000
P&U files for EU approval of glaucoma dual-therapy
24 February 2000
P&U files NDA for new glaucoma combination
11 January 2000
Aggrastat Backed For Unstable Angina
14 April 1998
Analysts Assess Outlook For US Drug Majors
8 January 1998
...Merck Confident It Can Hold Growth Rates
9 December 1997
Allergan Announces R&D Pipeline Developments
5 May 1997
First Launch Of P&U's Xalatan For Glaucoma
30 September 1996
First Approval Of Allergan's Alphagan
16 September 1996
First Approval For Novel Glaucoma Drug
24 June 1996
Indian drug Price Fixing Moves
26 February 1996
P&U's Latanoprost Gets Go-Ahead
18 December 1995
Merck pipline report
3 July 1995
Ciba Vision Launches Betimol In The USA
26 June 1995
Pharmacia Pipeline Promises Future Growth
20 March 1995
Mixed Six Month Results From Japan's Drugmakers
9 January 1995
IMPACT OF SWEDISH REFERENCE PRICING PLAN
6 June 1994
WORLD PRODUCT NEWS IN BRIEF
24 January 1994
MSD CUTS UK PRICES
4 October 1993
FALL IN PROFITS AT BANYU
22 June 1992
Showing 1-57 of 57 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
